A Multicentric, Open label, Randomized, Comparative, Parallel-group, Active-Controlled Phase III Clinical Trial to Evaluate Efficacy and Safety of oral tablets of Fixed-dose Combination of Cefpodoxime 200 mg and Ofloxacin 200 mg in Comparison with Cefpodoxime 200 mg alone in patients with respiratory tract infection [RTI] and typhoid fever.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 11 Dec 2013
At a glance
- Drugs Cefpodoxime; Cefpodoxime/ofloxacin
- Indications Respiratory tract infections; Typhoid
- Focus Therapeutic Use
- 29 Dec 2010 Status changed from recruiting to active, no longer recruiting as reported by Clinical Trials Registry - India record.
- 20 Nov 2010 New trial record